MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Postmenopausal Hormone Therapy in Unstable Angina

Phase 3
Completed
Conditions
Angina, Unstable
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Postmenopause
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000601

Multicenter Investigation of Limitation of Infarct Size (MILIS)

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000493

Control of Hypertension by Non-Pharmacologic Means

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000498

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

Phase 3
Completed
Conditions
Myocardial Ischemia
Coronary Arteriosclerosis
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Postmenopause
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000549

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

Phase 3
Completed
Conditions
Postmenopause
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000559

Hypertension Detection and Follow-up Program (HDFP)

Phase 3
Completed
Conditions
Heart Diseases
Cardiovascular Diseases
Hypertension
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000485

Post Coronary Artery Bypass Graft (CABG) Study

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000463

Multicenter Unsustained Tachycardia Trial (MUSTT)

Phase 3
Completed
Conditions
Arrhythmia
Cardiovascular Diseases
Coronary Disease
Death, Sudden, Cardiac
Heart Diseases
Myocardial Ischemia
Tachycardia, Ventricular
First Posted Date
1999-10-28
Last Posted Date
2017-01-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000480

Postmenopausal Estrogen/Progestin Interventions (PEPI)

Phase 3
Completed
Conditions
Bone Diseases
Thrombosis
Postmenopause
Cardiovascular Diseases
Coronary Disease
Diabetes Mellitus
Heart Diseases
Hypercholesterolemia
Hypertension
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-05-13
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000466

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

Phase 3
Completed
Conditions
Atrial Fibrillation
Cardiovascular Diseases
Arrhythmia
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000556
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy